目錄:北京索萊寶科技有限公司>>抗體>>Polyclonal Antibody>> K106631PAnti-CCL2 Polyclonal Antibody
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 50ul/100ul |
|---|---|---|---|
| 貨號 | K106631P | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,環(huán)保,化工,生物產(chǎn)業(yè),農(nóng)業(yè) |
| 主要用途 | IHC |
Anti-CCL2 Polyclonal Antibody
| 英文名稱 | Anti-CCL2 Polyclonal Antibody |
|---|---|
| 宿主 | Rabbit |
| 別名 | MCP1;SCYA2;MCP-1;HC11 |
| 應(yīng)用 | IHC |
| 稀釋比例 | IHC 1:50-200. |
| 交叉反應(yīng) | Human |
| 蛋白分子量 | 11kDa |
| Gene ID | 6347 |
| 保存 | Store at -20°C. Avoid freeze / thaw cycles. |
| 儲存液 | Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3. |
| 純化方法 | Affinity purification |
| 亞型 | IgG |
| 免疫原 | A synthetic peptide of human CCL2 |
| 性狀 | 液體 |
| Public Immunogen Range | A synthetic peptide of human CCL2 |
| Subcellular Locations | Cytoplasm |
| Swiss Prot | P13500 |
| 克隆類型 | Polyclonal Antibody |
| 背景資料 | Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. |
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)
15
化工儀器網(wǎng)